Similarly, sermorelin is a GHRH analog that was FDA approved for children with growth hormone deficiency
Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
By optimizing communication within the central nervous system, it promotes a calm, focused, and emotionally balanced state without the side effects of conventional medications.PE-22-28 also shows promise in supporting cognitive function, neuroplasticity, and recovery from neurological stress, making it a valuable addition to longevity and mental performance protocols.At The Biohacker, PE-22-28 Therapy is designed to support brain health, enhance mood stability, and improve resilience to stress
Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates
However, it is recommended not to use it at the same time with products that contain acidic ingredients, such as acidic products, AHA, or vitamin C products
